JCM
EBS icon

Jacobi Capital Management’s Emergent Biosolutions EBS Stock Holding History

Jacobi Capital Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10
Closed -$1K – 648
2021
Q3 		$1K Sell
10
-264
-96% -$16K ﹤0.01% 1374
2021
Q2 		$17K Buy
274
+72
+36% +$4.63K ﹤0.01% 880
2021
Q1 		$19K Buy
202
+84
+71% +$8.6K ﹤0.01% 789
2020
Q4 		$11K Buy
118
+18
+18% +$1.65K ﹤0.01% 844
2020
Q3 		$10K Buy
+100
New +$10.8K ﹤0.01% 800

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jacobi Capital Management's EBS Position: Q4 2021 in Review

Jacobi Capital Management sold out of Emergent Biosolutions (EBS) in Q4 2021, closing a stake of 10 shares — an estimated $1K sold.

Jacobi Capital Management first reported a position in EBS in Q3 2020 and held it in 5 quarters. The position peaked at $19K in Q1 2021. 254 funds tracked by Wall St. Rank hold EBS as of Q4 2021.

  • Jacobi Capital Management reported no remaining Emergent Biosolutions position as of Q4 2021 after selling out during the quarter.
  • Jacobi Capital Management sold 10 Emergent Biosolutions shares in Q4 2021, an estimated $1K.
  • Jacobi Capital Management first reported a position in Emergent Biosolutions in Q3 2020 and held it in 5 quarters.
  • Jacobi Capital Management's Emergent Biosolutions position peaked at $19K in Q1 2021.
  • 254 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2021.

Based on Jacobi Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.